Glenmark USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials Read more
Novo Nordisk’s Ozempic gains USFDA approves to cut risk of diabetic kidney disease progression Read more
